))
McGill Cares: Update on New Medications to Treat Alzheimer’s Disease
Manage episode 377516126 series 3465934
Content provided by McGill Dementia Education Program. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by McGill Dementia Education Program or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Serge Gauthier, MD, is a clinical neurologist specializing in the development of new tools for diagnosis and treatments for people living with Alzheimer’s disease. He is the Academic Co-Lead for the Dementia Education Program and Professor Emeritus in the Department of Neurology & Neurosurgery and the Department of Psychiatry at McGill University. Dr. Gauthier was the Director of the McGill University Research Centre for Studies in Aging from 1986 to 1997. His accomplishments led to him being appointed to the Order of Canada in 2014 and the National Order of Québec in 2017.
Dr. Gauthier will provide an overview of new pharmaceuticals on the market, including how they obtained Health Canada and/or FDA approval, how they work, who is eligible, side effects, availability and cost.
This podcast is also available in French.
______________________________________________
McGill Cares is supported by the Amelia Saputo Community Outreach for Dementia Care.
McGill Cares is an initiative of the McGill Dementia Education Program, which is funded by private donations. To contribute or for more information about our program, please visit http://www.mcgill.ca/dementia. This page also contains a link to trusted resources specific to dementia.
If you have any topics or questions that you would like us to address during our weekly webcasts, please email us at dementia@mcgill.ca.
118 episodes
Share
